Determinants for Predicting Serious Adverse Event (SAE) Rates Across Study Duration in Selected CNS Indications

Time

Wed, Jun 26 11:45AM
W 03

Title

Determinants for Predicting Serious Adverse Event (SAE) Rates Across Study Duration in Selected CNS Indications

Abstract Summary

Using an Illustrative data set, three CNS indications, Depression, Alzheimer’s and Parkinson’s disease, were selected for review. Numbers of patients randomized were compared to SAE numbers for study duration. Final SAE numbers for completed trials are publicly available at clinicaltrials.gov.

Poster Presenter

Dena Cosgrove
RPh,
Global Head, Safety Aggregate Reporting and Analytics,
Quintiles, Inc.
United States

© 2015 DIA